News Archive

The ARISTOTLE study found that apixaban was superior to warfarin in preventing stroke and decreasing risk of bleeding for patients with atrial fibrillation.

The DCRI’s Adrian Hernandez, MD, MHS, and Manesh Patel, MD, will serve as Duke’s representatives to the consortium.

The DCRI has joined a new alliance focused on bringing digital therapeutics solutions to patients.

While heart disease is the leading cause of death in the United States, relatively few of these patients receive a referral to palliative care, focusing on quality of life and value-based treatment

​ Several DCRI faculty members are developing a new professional development program for early- to mid-career female clinical researchers offered by the American College of Cardiology. The Clinical Trials Research Program is a training and networking program open to women cardiologists who have committed to a career in clinical research and have been nominated by their institution for further development in research leadership.

The DCRI was recognized in five categories, including Capabilities, Compatibility, Expertise, Phase IV, and Reliability.

Through projects such as ADAPTABLE, CTTI, and the NIH Collaboratory, the DCRI is defining how to use RWE in clinical research.

The ARLG and COMBACTE will work together on a number of initiatives designed to fight drug-resistant infections.

The DCRI serves as the Coordinating Center for the program, which received single IRB approval to proceed with its expansive observational research.

DCRI researchers found that heart failure patients are much more likely to take a guideline-recommended medication if they are started on the drug while still in the hospital.